Autologous bone marrow mononuclear cell administration in a large cohort of 1,011 patients with autism spectrum disorder: a retrospective observational study
Clinical Transplantation and Research · 31.03.2026 · 40 (1) · 116-128
DOI: 10.4285/ctr.25.0009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation and Research, online erschienen am 18.12.2025. Verfasst von Alok Sharma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Services, NeuroGen Brain and Spine Institute, Navi Mumbai, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
This retrospective observational study analyzed the therapeutic efficacy of autologous bone marrow mononuclear cells (BMMNCs) in a large cohort of patients with autism spectrum disorder (ASD).
Methods
Overall, 1,011 patients with ASD who received intrathecal administration of autologous BMMNCs were included. Changes in symptoms and outcome measures-the Indian Scale of Autism Assessment (ISAA) and Childhood Autism Rating Scale (CARS)-were recorded. Brain positron emission tomography computed tomography (PET/CT) was used to objectively assess changes in brain metabolism.
Results
At a mean follow-up of 19.3 months, 90.6% of patients showed improvement after cell therapy. Symptomatic improvements were observed in attention and concentration, command following, eye contact, sitting tolerance, social interaction, hyperactivity, communication, speech, stereotypical behavior, aggressiveness, and self-injurious behavior. Patients who received multiple doses of cell therapy demonstrated better outcomes, and improvements were seen across all age groups and regardless of disease severity. Changes in ISAA and CARS scores were statistically significant (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Services, NeuroGen Brain and Spine Institute, Navi Mumbai, India.
- Department of Research and Development, NeuroGen Brain and Spine Institute, Navi Mumbai, India.
- Department of Neurorehabilitation, NeuroGen Brain and Spine Institute, Navi Mumbai, India.
- Department of Regenerative Laboratory, NeuroGen Brain and Spine Institute, Navi Mumbai, India.
ORCID-Profile: Alok Sharma, Nandini Gokulchandran, Hemangi Sane, Pooja Kulkarni, Krishnaveni Kannan, Zubiya Shaikh, Hema Biju, Amruta Paranjape, Myola D'sa, Prerna Badhe
Zitieren
APA
Sharma, A., Gokulchandran, N., Sane, H., Kulkarni, P., Kannan, K., Shaikh, Z., Biju, H., Paranjape, A., D'sa, M., & Badhe, P. (2026). Autologous bone marrow mononuclear cell administration in a large cohort of 1,011 patients with autism spectrum disorder: a retrospective observational study. Clinical Transplantation and Research, 40(1), 116-128. https://doi.org/10.4285/ctr.25.0009
Vancouver
Sharma A, Gokulchandran N, Sane H, Kulkarni P, Kannan K, Shaikh Z, et al. Autologous bone marrow mononuclear cell administration in a large cohort of 1,011 patients with autism spectrum disorder: a retrospective observational study. Clinical Transplantation and Research. 2026;40(1):116-128. doi:10.4285/ctr.25.0009
BibTeX
@article{Sharma2026,
author = {Sharma, Alok and Gokulchandran, Nandini and Sane, Hemangi and Kulkarni, Pooja and Kannan, Krishnaveni and Shaikh, Zubiya and Biju, Hema and Paranjape, Amruta and D'sa, Myola and Badhe, Prerna},
title = {Autologous bone marrow mononuclear cell administration in a large cohort of 1,011 patients with autism spectrum disorder: a retrospective observational study},
journal = {Clinical Transplantation and Research},
year = {2026},
volume = {40},
number = {1},
pages = {116--128},
doi = {10.4285/ctr.25.0009}
}
EUVIMED